Q
QuantAbundanceAbundância, quantificada.

Notícias

Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

30,455 signal articles · 146 in last 24h · 154,143 total before filter · latest 1h ago
146last 24h
877last 7d
147● bullish (7d)
96● bearish (7d)
214publishers
AllMacro211Earnings108M&A126Regulatory21Product21Analyst17
✕ clear all filtersticker: ABTsentiment: neutralSentiment:bullishneutralbearishshow all (incl. clickbait)
FDA Approves Abbott's First Wearable Device for Dual Ketone and Glucose Tracking
Benzinga29d agoneutral
FDA Approves Abbott's First Wearable Device for Dual Ketone and Glucose Tracking

The U.S. Food and Drug Administration (FDA) on Tuesday approved Abbott Laboratories’ (NYSE:ABT) Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System for diabetes patients aged two and older. The regulatory nod makes the device the first wearable in the U.S. to monitor ketone levels continuously. It also represents the first global system to track blood sugar and ketones simultaneously within a single unit. Clinical Data And De Novo Pathway The agency granted marketing authorization